Inhibition of microRNA-299-5p sensitizes glioblastoma cells to temozolomide via the MAPK/ERK signaling pathway.

Peng Y, He X, Chen H, Duan H, Shao B, Yang F, Li H, Yang P, Zeng Y, Zheng J, Li Y, Hu J, Lin L, Teng L

DOI: 10.1042/bsr20181051
Published: 2018 Oct 31
Container: Bioscience reports
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1042/bsr20181051,
  title = {Inhibition of microRNA-299-5p sensitizes glioblastoma cells to temozolomide via the MAPK/ERK signaling pathway.},
  author = {Peng Y and He X and Chen H and Duan H and Shao B and Yang F and Li H and Yang P and Zeng Y and Zheng J and Li Y and Hu J and Lin L and Teng L},
  year = {2018},
  journal = {Bioscience reports},
  doi = {10.1042/bsr20181051},
  url = {https://doi.org/10.1042/bsr20181051}
}

RIS

TY  - JOUR
TI  - Inhibition of microRNA-299-5p sensitizes glioblastoma cells to temozolomide via the MAPK/ERK signaling pathway.
AU  - Peng Y
AU  - He X
AU  - Chen H
AU  - Duan H
AU  - Shao B
AU  - Yang F
AU  - Li H
AU  - Yang P
AU  - Zeng Y
AU  - Zheng J
AU  - Li Y
AU  - Hu J
AU  - Lin L
AU  - Teng L
PY  - 2018
JO  - Bioscience reports
DO  - 10.1042/bsr20181051
UR  - https://doi.org/10.1042/bsr20181051
ER  -

APA

Y, P., X, H., H, C., H, D., B, S., F, Y., H, L., P, Y., Y, Z., J, Z., Y, L., J, H., L, L., & L, T. (2018). Inhibition of microRNA-299-5p sensitizes glioblastoma cells to temozolomide via the MAPK/ERK signaling pathway.. Bioscience reports. https://doi.org/10.1042/bsr20181051

Source records

pubmed · retrieved 2026-09-25T00:21:03.548Z